Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry.

Amat-Santos IJ, Martin-Yuste V, Fernández-Díaz JA, Martin-Moreiras J, Caballero-Borrego J, Salinas P, Ojeda S, Rivero F, Núñez Villota J, Mohandes M, Dubois D, Bosa Ojeda F, Rumiz E, de la Torre Hernández JM, Jiménez-Mazuecos J, Lacunza J, Tejedor P, Gómez I, Goncalves-Ramirez LR, Rojas P, Sabaté M, Goicolea J, Diego Nieto A, Jiménez-Fernández M, Escaned J, Gonzalo N, Pardo L, Cuesta J, Miñana G, Sanchis J, Rojas S, Millán R, Vaquerizo B, Rodríguez S, Lee DH, Morales FJ, Gutiérrez A, López M, Maristany J, Rondán J, Galeote G, Kabbanni Z, Rodríguez S, Teruel L, Sadaba M, Jurado A, Mainar V, Sánchez-Rubio J, Vinhas H, Fernandes R.

Rev Esp Cardiol (Engl Ed). 2019 May;72(5):373-382. doi: 10.1016/j.rec.2018.05.020. Epub 2018 Jun 25. English, Spanish.

PMID:
29954721
2.

The single IGF-1 partial deficiency is responsible for mitochondrial dysfunction and is restored by IGF-1 replacement therapy.

Olleros Santos-Ruiz M, Sádaba MC, Martín-Estal I, Muñoz U, Sebal Neira C, Castilla-Cortázar I.

Growth Horm IGF Res. 2017 Aug;35:21-32. doi: 10.1016/j.ghir.2017.05.007. Epub 2017 Jun 2.

PMID:
28648804
3.

STEMI with fluctuating closing of LAD and Cx: Do not concentrate on the finger.

Sadaba M, Subinas A, Rumoroso JR.

Cardiovasc Revasc Med. 2017 Jul - Aug;18(5S1):S35-S39. doi: 10.1016/j.carrev.2017.03.024. Epub 2017 Mar 27.

PMID:
28499664
4.

Insulin-like growth factor 1 (IGF-1) therapy: Mitochondrial dysfunction and diseases.

Sádaba MC, Martín-Estal I, Puche JE, Castilla-Cortázar I.

Biochim Biophys Acta. 2016 Jul;1862(7):1267-78. doi: 10.1016/j.bbadis.2016.03.010. Epub 2016 Mar 25. Review.

5.

Partial IGF-1 deficiency induces brain oxidative damage and edema, which are ameliorated by replacement therapy.

Puche JE, Muñoz Ú, García-Magariño M, Sádaba MC, Castilla-Cortázar I.

Biofactors. 2016 Jan-Feb;42(1):60-79. doi: 10.1002/biof.1255. Epub 2016 Feb 1.

PMID:
26891019
6.

Mechanisms Underlying Testicular Damage and Dysfunction in Mice With Partial IGF-1 Deficiency and the Effectiveness of IGF-1 Replacement Therapy.

Castilla-Cortázar I, Gago A, Muñoz Ú, Ávila-Gallego E, Guerra-Menéndez L, Sádaba MC, García-Magariño M, Olleros Santos-Ruiz M, Aguirre GA, Puche JE.

Urology. 2015 Dec;86(6):1241.e1-9. doi: 10.1016/j.urology.2015.09.012. Epub 2015 Sep 25.

PMID:
26408501
7.

IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand.

Guerra-Menéndez L, Sádaba MC, Puche JE, Lavandera JL, de Castro LF, de Gortázar AR, Castilla-Cortázar I.

J Transl Med. 2013 Oct 25;11:271. doi: 10.1186/1479-5876-11-271.

8.

Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions.

Sádaba MC, Tzartos J, Paíno C, García-Villanueva M, Alvarez-Cermeño JC, Villar LM, Esiri MM.

J Neuroimmunol. 2012 Jun 15;247(1-2):86-94. doi: 10.1016/j.jneuroim.2012.03.020. Epub 2012 Apr 23.

PMID:
22531276
9.

Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study.

de la Torre Hernandez JM, Hernández Hernandez F, Alfonso F, Rumoroso JR, Lopez-Palop R, Sadaba M, Carrillo P, Rondan J, Lozano I, Ruiz Nodar JM, Baz JA, Fernandez Nofrerias E, Pajin F, Garcia Camarero T, Gutierrez H; LITRO Study Group (Spanish Working Group on Interventional Cardiology).

J Am Coll Cardiol. 2011 Jul 19;58(4):351-8. doi: 10.1016/j.jacc.2011.02.064.

10.

Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis.

Villar LM, Espiño M, Cavanillas ML, Roldán E, Urcelay E, de la Concha EG, Sádaba MC, Arroyo R, González-Porqué P, Alvarez-Cermeño JC.

Clin Immunol. 2010 Oct;137(1):51-9. doi: 10.1016/j.clim.2010.06.007.

PMID:
20621566
11.

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.

Villar LM, Masterman T, Casanova B, Gómez-Rial J, Espiño M, Sádaba MC, González-Porqué P, Coret F, Alvarez-Cermeño JC.

J Neuroimmunol. 2009 Jun 25;211(1-2):101-4. doi: 10.1016/j.jneuroim.2009.03.003. Epub 2009 May 13.

PMID:
19443047
12.

Coronary stent immobilization during angioplasty by transcoronary ventricular pacing via a guidewire.

Lasa G, Larman M, Gaviria K, Sanmartín JC, Sádaba M, Rumoroso JR.

Rev Esp Cardiol. 2009 Mar;62(3):288-92. English, Spanish.

13.

Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment.

García-Barragán N, Villar LM, Espiño M, Sádaba MC, González-Porqué P, Alvarez-Cermeño JC.

Eur J Neurol. 2009 Mar;16(3):380-5. doi: 10.1111/j.1468-1331.2008.02504.x.

PMID:
19175382
14.

Influence of oligoclonal IgM specificity in multiple sclerosis disease course.

Villar L, García-Barragán N, Espiño M, Roldán E, Sádaba M, Gómez-Rial J, González-Porqué P, Alvarez-Cermeño J.

Mult Scler. 2008 Mar;14(2):183-7. Epub 2007 Oct 17.

PMID:
17942517
15.

Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis.

Villar LM, García-Barragán N, Sádaba MC, Espiño M, Gómez-Rial J, Martínez-San Millán J, González-Porqué P, Alvarez-Cermeño JC.

J Neurol Sci. 2008 Mar 15;266(1-2):34-7. Epub 2007 Sep 19.

PMID:
17884100
16.

Interruption of blood flow during compression and radial artery occlusion after transradial catheterization.

Sanmartin M, Gomez M, Rumoroso JR, Sadaba M, Martinez M, Baz JA, Iniguez A.

Catheter Cardiovasc Interv. 2007 Aug 1;70(2):185-9.

PMID:
17203470
17.

Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.

Masjuan J, Alvarez-Cermeño JC, García-Barragán N, Díaz-Sánchez M, Espiño M, Sádaba MC, González-Porqué P, Martínez San Millán J, Villar LM.

Neurology. 2006 Feb 28;66(4):576-8.

PMID:
16505315
18.

Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.

Villar LM, Masjuan J, Sádaba MC, González-Porqué P, Plaza J, Bootello A, Alvarez-Cermeño JC.

Arch Neurol. 2005 Apr;62(4):574-7.

PMID:
15824255
19.

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

Villar LM, Sádaba MC, Roldán E, Masjuan J, González-Porqué P, Villarrubia N, Espiño M, García-Trujillo JA, Bootello A, Alvarez-Cermeño JC.

J Clin Invest. 2005 Jan;115(1):187-94.

20.

An ultrasensitive method for the detection of oligoclonal IgG bands.

Sádaba MC, González Porqué P, Masjuan J, Alvarez-Cermeño JC, Bootello A, Villar LM.

J Immunol Methods. 2004 Jan;284(1-2):141-5.

PMID:
14736424

Supplemental Content

Loading ...
Support Center